GHTC joined a civil society statement from the Global Health Council—in response to the special session of the World Health Organization (WHO) Executive Board (EB)—imploring WHO member states to take urgent action to accelerate the development and equitable global delivery of COVID-19 technologies.
PDF
GHTC issued the following statement regarding the release of the revised House Heroes Act released yesterday. GHTC applauds the inclusion of emergency funding to support the international response to COVID-19 and urges congressional champions to support additional investment opportunities to resource the US Agency for International Development (USAID)’s Global Health Bureau to advance COVID-19 technologies.
Learn more
GHTC endorsed a Global Health Council letter urging Congress to allocate at least US$20 billion in emergency supplemental funding for programs funded through the International Affairs Budget, including at least $11 billion for bilateral global health programs and the multilateral response to support a holistic global response to COVID-19.
PDF
GHTC has joined partners to issue a call to action through the G20 Health and Development partnership, urging leaders to fully fund the Access to COVID-19 Tools Accelerator, commit to greater investment and focus on antimicrobial resistance, incentivize sustainable funding models for capacity-building and preparedness, and recognize and act upon the recommendations from the Global Preparedness Monitoring Board and the Independent Panel for Pandemic Preparedness and Response.
PDF
GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2022 (FY22) budget.
PDF
GHTC Director Jamie Bay Nishi was quoted in an article in the August Bulletin of the World Health Organization (WHO) on accelerating regulatory processes for COVID-19 technologies.
PDF
Today, the European Medicines Agency adopted a positive opinion under Article 58 for use of the monthly dapivirine ring by cisgender women ages 18 and older in developing countries—a move that we at the GHTC applaud as a major milestone for women’s HIV prevention efforts.
Learn more
GHTC joined a scientific community letter to Congressional leaders urging Congress do do everything possible to maintain the United States' membership and funding for the World Health Organization (WHO).
PDF